Leaflet GAMMANORM 165mg / ml solution for injection


Indicated for: immunosuppression

Route of administration: injectable

Substance: normal human immunoglobulin (immunoglobulin)

ATC: J06BA01 (Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human)

Normal human immunoglobulin is used for the treatment and prevention of infections in patients with primary or secondary immune deficiencies. It contains antibodies that help strengthen the immune system.

The medication is administered intravenously, as directed by a doctor. The dose and frequency of administration are adjusted based on the patient's condition.

Side effects may include headache, fever, nausea, or injection site reactions. In rare cases, severe allergic reactions or thrombosis may occur.

Normal human immunoglobulin is not recommended for patients with hypersensitivity to human immunoglobulins or severe IgA deficiency.

General data about GAMMANORM 165mg / ml

  • Substance: normal human immunoglobulin
  • Date of last drug list: 01-07-2020
  • Commercial code: W57505004
  • Concentration: 165mg / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: OCTAPHARMA AB - SUEDIA
  • Holder: OCTAPHARMA (IP) SPRL - BELGIA
  • Number: 7670/2015/02
  • Shelf life: 3 years-after packing for marketing;dupa prima desschidere a flac.-it is used immediately

Concentrations available for normal human immunoglobulin

  • 100g/l
  • 100mg/ml
  • 165mg/ml
  • 200mg/ml